🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Interested in #addiction medicine, expert #networks, or both? Join us for the 1st ISAM Global Expert Network webinar, where we'll discuss the development of the #ISAM_GEN and how you can contribute! 🗓 Thursday 11 November ➡ Registration Link: eventbrite.com/e/isam-global-…

INTAM_Network, VICONS_Networks, INTF_Network, and ISAM-Neuroscience Interest Group (ISAM-NIG) joint Webinar: Optimized Non-Invasive Brain Stimulation for Addiction Treatment🧠 led by Hamed Ekhtiari Colleen Hanlon ⏰July 27, 2022, 10:00 AM - 12:00 PM ET 💰Free registration: eventbrite.com/e/optimized-no…

🎙️ If you missed our webinars on "Dose-Response in Non-Invasive Brain Stimulation" in collab with INTAM_Network ISAM-Neuroscience Interest Group (ISAM-NIG) VICONS_Networks ENIGMA ACRI Network UMN Medical Discovery Team on Addiction, they're available to watch on YouTube. 🎥 Webinar 1: youtube.com/playlist?list=… 🎥 Webinar 2: youtube.com/playlist?list=…

🗣️ Just announced: Join us on April 06 for a free webinar discussing Precision Functional Mapping for Individualized Neuromodulation. 💰 Free registration: eventbrite.com/e/precision-fu…

Join us on June 20th, 6:30-7:30 pm at #CPDD2023 if you are interested in joining and discussing the achievements and the road ahead of the ENIGMA Addiction Cue Reactivity Initiative (ACRI). cpdd.societyconference.com/conf/#sessions… RSVP here if you are planning to join. docs.google.com/forms/d/e/1FAI…

#ACNP2023 My Way or the Highway: Methodological Reporting Checklists to Promote Transparency and Reproducibility in Brain Studies, Do they help or add burden and suppress innovation? Sarah "Holly" Hollingsworth Lisanby, MD tony george Dost Öngür Shari Wiseman Thomas Nichols @nichols.bsky.social Charlotte Stagg @dmoher

In this paper by the Addiction Cue Reactivity Initiative ENIGMA ACRI Network, the authors assess the current state of fMRI cue reactivity research, highlighting opportunities and challenges to develop clinically-relevant biomarkers of addiction and recovery. ja.ma/49ss2ey

The ACRI network's biomarker development roadmap and systematic review of 415 papers spanning 25 years of fMRI drug cue-reactivity research is out in JAMA Psychiatry, with Arshiya Sangchooli (He/They) and Mehran Zare-Bidoky as co-first authors and led by Hamed Ekhtiari. Congratulations to all 68 co-authors.